First SARS-CoV-2 Omicron infection as an effective immune booster among mRNA vaccinated individuals: final results from the first phase of the PRIBIVAC randomised clinical trial
Article in EBioMedicine (August 2024)
The most recent citing publications are shown below. View all 7 publications that cite this research output on Dimensions.
Article in EBioMedicine (August 2024)
Article in Vaccine (May 2024)
Article (April 2024)